FDA Approved Products
6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
EUTHYROX
levothyroxine sodium
LOE Approaching
ORAL · TABLET
hypothyroidism during the recovery phase of subacute thyroiditissecondary (pituitary)+3
2002
NDA30/100
EVAMIST
estradiol
LOE Approaching
Design Pharmaceuticals
TRANSDERMAL · SPRAY
2007
NDA30/100
EVISTA
raloxifene hydrochloride
LOE Approaching
Eli Lilly and Company
ORAL · TABLET
invasive breast cancerreduction of the risk of recurrence of breast cancer+4
2007
NDA30/100
EVISTA
raloxifene hydrochloride
LOE Approaching
Eli Lilly and Company
ORAL · TABLET
invasive breast cancerreduction of the risk of recurrence of breast cancer+4
1997
NDA30/100
EVOCLIN
clindamycin phosphate
LOE Approaching
TOPICAL · AEROSOL, FOAM
2004
NDA30/100
EVOXAC
cevimeline hydrochloride
LOE Approaching
ORAL · CAPSULE
symptoms of dry mouth in patients with Sjögren's Syndrome
2000
NDA30/100
EXALGO
hydromorphone hydrochloride
LOE Approaching
ORAL · TABLET, EXTENDED RELEASE
moderate to severe pain in opioid tolerant patients requiring continuousaround-the-clock opioid analgesia for an extended period of time ()
2010
NDA30/100
EXCEDRIN (MIGRAINE RELIEF)
acetaminophen, asprin, caffeine
LOE Approaching
GSK
ORAL · TABLET
migraine
1998
NDA30/100
EXELDERM
sulconazole nitrate
LOE Approaching
Journey Medical
TOPICAL · SOLUTION
tinea cruristinea corporis caused by Trichophyton rubrum+3
1985
NDA30/100
EXELDERM
sulconazole nitrate
LOE Approaching
Journey Medical
TOPICAL · CREAM
tinea pedis (athlete's foot)tinea cruris+5
1989
NDA30/100
EXELON
rivastigmine tartrate
LOE Approaching
Novartis
ORAL · SOLUTION
dementia of the Alzheimer's type (AD)mild-to-moderate dementia associated with Parkinson's disease (PDD)+2
2000
NDA30/100
EXELON
rivastigmine tartrate
LOE Approaching
Novartis
ORAL · CAPSULE
dementia of the Alzheimer's type (AD)mild-to-moderate dementia associated with Parkinson's disease (PDD)+2
2000
NDA30/100
EXELON
rivastigmine
LOE Approaching
Novartis
TRANSDERMAL · FILM, EXTENDED RELEASE
dementia of the Alzheimer's type (AD)mild-to-moderate dementia associated with Parkinson's disease (PDD)+2
2007
NDA30/100
EXFORGE
amlodipine besylate and valsartan
LOE Approaching
Novartis
ORAL · TABLET
hypertensionto lower blood pressure: In patients not adequately controlled on monotherapy ()+8
2007
SMNDA30/100
EXFORGE HCT
amlodipine valsartan and hydrochlorothiazide
LOE Approaching
Novartis
ORAL · TABLET
hypertensionto lower blood pressure+2
2009
NDA30/100
EXIDINE
chlorhexidine gluconate
LOE Approaching
TOPICAL · SOLUTION
bacteriageneral skin cleansing
1985
NDA30/100
EXIDINE
chlorhexidine gluconate
LOE Approaching
TOPICAL · AEROSOL, METERED
bacteria
1984
NDA30/100
EXJADE
deferasirox
LOE Approaching
Novartis
ORAL · TABLET, FOR SUSPENSION
chronic iron overload in patients 10 years of ageolder with non-transfusion-dependent thalassemia (NTDT) syndromes+5
2005
NDA30/100
EXNA
benzthiazide
LOE Approaching
ORAL · TABLET
1960
NDA30/100
EXOSURF NEONATAL
cetyl alcohol; colfosceril palmitate; tyloxapol
LOE Approaching
GSK
INTRATRACHEAL · FOR SUSPENSION
1990
NDA30/100
EXSERVAN
riluzole
Peak
ORAL · FILM
amyotrophic lateral sclerosis (ALS) ( )
2019
SMNDA30/100
EXTINA
ketoconazole
LOE Approaching
TOPICAL · AEROSOL, FOAM
2007
SMNDA30/100
EXTRA-STRENGTH AIM
sodium monofluorophosphate
LOE Approaching
DENTAL · GEL
1986
NDA30/100
EXTRANEAL
icodextrin, sodium chloride, sodium lactate, calcium chloride, magnesium chloride
LOE Approaching
Vantive
INTRAPERITONEAL · SOLUTION
(compared to 4
2002
NDA30/100